Liver Changes in Cystic Fibrosis: What a New Study Found
Researchers examined liver health in children with cystic fibrosis and found that liver involvement is common but often goes unnoticed. Understanding these patterns may help doctors catch problems earlier.
Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.
Key takeaways
- About 1 in 6 children with CF in this study showed abnormal liver function test results
- Ultrasound imaging revealed liver changes in roughly 28% of children who were scanned, even though most had no symptoms
- Cystic fibrosis-associated liver disease is hard to diagnose because there's no single agreed-upon definition and many patients don't feel sick
- Regular monitoring with blood tests and imaging may help identify liver involvement before symptoms develop
Why Liver Health Matters in Cystic Fibrosis
Cystic fibrosis affects the lungs and pancreas—but it can also damage the liver. When this happens, doctors call it cystic fibrosis-associated liver disease, or CFALD. The problem is that CFALD is tricky to spot. Many children don't feel sick, there's no standard way to diagnose it, and simple blood or imaging tests don't always catch it early.
A new study from 2025 looked at how often liver problems actually occur in children with CF and what those problems look like.
Who Was in the Study
Researchers reviewed records from 60 children with cystic fibrosis, ranging in age from less than 1 year to 18 years old. About half were boys. All of these children had at least one liver test or an ultrasound scan, regardless of whether they had symptoms.
The study excluded children who had other liver or kidney diseases, cerebral palsy, or type 1 diabetes, so the findings focus specifically on liver changes linked to CF itself.
What the Researchers Found
About 1 in 6 children (16.6%) showed abnormal results on liver function blood tests. When doctors looked at ultrasound images, liver changes appeared in about 28% of the children who were scanned—that's 13 out of 47 kids. These changes included an enlarged liver, an uneven grainy appearance, or fatty buildup in the liver tissue.
The important finding: most of these children had no symptoms and wouldn't have been identified as having liver problems without testing.
What This Means
This study adds to what we know about how common liver involvement is in cystic fibrosis. Because many children show no warning signs, regular screening with blood tests and imaging may be important for catching problems early.
The study also highlights a real challenge in CF care: there's no agreed-upon definition of CFALD, which makes it harder for doctors to know when to start treatment and easier for milder cases to slip through the cracks. More research is needed to develop clearer diagnostic tools and to understand which liver changes matter most for a child's long-term health.
Evidence label
Source: BMC gastroenterology. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Related reading
More evidence-labeled coverage across the Type1Cure library.
- Causes & What We KnowPregnant Women with Diabetes Show Higher Rates of Toxoplasma InfectionPubMed indexed literature
- Causes & What We KnowExploring Rare Breast Inflammation: What BRCA Mutations and Type 1 Diabetes May SharePubMed indexed literature
- Causes & What We KnowUnderstanding Type 1 Diabetes: A Shift Toward Early InterventionPubMed indexed literature
- Causes & What We KnowHow Nutrition, Metabolism, and Immunity Connect: What the Lectin Pathway Tells UsPubMed indexed literature
- Causes & What We KnowWhy Do Finland and Sardinia Have So Much Type 1 Diabetes? Genetics Offers a New CluePubMed indexed literature
- Causes & What We KnowA Rare Skin Condition in Young Children with Type 1 Diabetes: What Parents Should KnowPubMed indexed literature